130 results
Page 4 of 7
8-K
EX-99.1
uzs0fx cjfea5
12 Nov 20
PDS Biotechnology Reports Financial Results for the Third Quarter 2020 and Provides Business Update
4:31pm
8-K
EX-1.1
mifizhe45fclou8ehxrp
13 Aug 20
PDS Biotechnology Corporation Announces Proposed Public Offering of Common Stock
4:30pm
8-K
EX-10.1
swozz4eylf
24 Jun 20
NCI-led Phase 2 clinical trial of this reported combination was initiated in June 2020
4:30pm
424B4
1ud2een62qhk8
12 Feb 20
Prospectus supplement with pricing info
5:22pm
424B3
570plfj
29 Aug 19
Prospectus supplement
4:08pm